WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹904 Cr | ₹760 Cr | ₹631 Cr | ₹513 Cr | ₹466 Cr |
What is the latest Revenue of WINDLAS BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹904 Cr |
| Mar2025 | ₹760 Cr |
| Mar2024 | ₹631 Cr |
| Mar2023 | ₹513 Cr |
| Mar2022 | ₹466 Cr |
How is Revenue of WINDLAS BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹904 Cr | 18.98 | |
| Mar2025 | ₹760 Cr | 20.43 | |
| Mar2024 | ₹631 Cr | 22.97 | |
| Mar2023 | ₹513 Cr | 10.12 | |
| Mar2022 | ₹466 Cr | - | |
Compare Revenue of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,755.3 Cr | -3.4% | 1.4% | -8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -3.4% |
1.4% |
-8.5% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses